A pilot study to compare the response of psoriasis to narrow-band UVB phototherapy in the morning and afternoon (Psoriasis and the Circadian Timing System [Version 1])

ewcastle upon Tyne Hospitals NHS Foundation Trust0 sites20 target enrollmentApril 23, 2020

Overview

No summary available.

Registry

who.int

Start Date

April 23, 2020

End Date

October 31, 2020

Last Updated

5 years ago

Study Type

Interventional

Sex

All

Sponsor

ewcastle upon Tyne Hospitals NHS Foundation Trust

•1\. Able to control their psoriasis or already controlled by topical therapy
•2\. Pregnant
•3\. Significant sun exposure, sun\-bed use or previous NbUVB within the last month or be planning significant sun exposure or sun\-bed use in the next month
•4\. Previously taken, in the last three months any of the following: methotrexate, azathioprine, ciclosporin, biological therapy or systemic steroids for treatment of psoriasis
•5\. Previously taken, in the last month, any oral photosensitising medications, including: thiazide diuretics, antibiotics such as tetracyclines and quinolones, non\-steroidal anti\-inflammatory drugs, phenothiazines, retinoids, sulphonylureas, quinine and St John’s Wort
•6\. Also suffer from diseases where phototherapeutic treatment is contraindicated: xeroderma pigmentosum, lupus erythematosus
•7\. Work night\-shifts
•8\. Diagnosed circadian rhythm disorder